STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
LONDON — English health authorities on Thursday agreed to provide a breast cancer drug from AstraZeneca through the National Health Service, ending a years-long dispute that stoked questions about how committed the pharma company was to the U.K…
ImpactMinor 13/100
Why it mattersRule-based estimate: soft/evergreen signals; trust 8/10.
RegionsGlobal
Published1 d ago (Thu, 17 Sep 2026 07:42:48 GMT)
RetrievedThu, 17 Sep 2026 08:30:17 GMT via rss
ClassifiedThu, 17 Sep 2026 08:30:25 GMT by heuristic
AuthorAndrew Joseph